CGEN · NASDAQ
Compugen (CGEN) Stock Price & Fundamentals
Compugen (CGEN) closed at $632.50 on Oct 9, 2026, up less than 0.01% from the previous close of $632.48.
Share price, past year
1Y +21.09%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $632.50 |
| Sep 30, 2026 | $624.82 |
| Aug 31, 2026 | $626.46 |
| Jul 31, 2026 | $659.53 |
| Jun 30, 2026 | $623.16 |
| May 29, 2026 | $585.95 |
| Apr 30, 2026 | $565.05 |
| Mar 31, 2026 | $542.65 |
| Feb 27, 2026 | $564.50 |
| Jan 30, 2026 | $544.92 |
| Dec 31, 2025 | $547.51 |
| Nov 28, 2025 | $536.33 |
| Oct 31, 2025 | $538.34 |
Key statistics
- Market cap
- $59.80B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 94.6M
- Dividend yield
- —
- 52-week range
- $520.32 – $666.75
Compugen's market cap is $59.80B, based on a share price of $632.50 and 94.6M shares outstanding as of Dec 31, 2025.
Financials
Compugen reported revenue of $72.76M for fiscal 2025, up 161.14% from fiscal 2024.
Compugen earned net income of $35.34M in fiscal 2025, a net margin of 48.6%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $72.76M | +161.1% | $35.34M | 48.6% | $0.38 | $31.33M |
| FY2024ended Dec 31, 2024 | $27.86M | −16.7% | −$14.23M | −51.1% | −$0.16 | $49.49M |
| FY2023ended Dec 31, 2023 | $33.46M | +346.1% | −$18.75M | −56.1% | −$0.21 | −$36.06M |
| FY2022ended Dec 31, 2022 | $7.50M | +25.0% | −$33.69M | −449.3% | −$0.39 | −$34.59M |
| FY2021ended Dec 31, 2021 | $6.00M | +200.0% | −$34.20M | −570.1% | −$0.41 | −$22.98M |
| FY2020ended Dec 31, 2020 | $2.00M | −88.8% | −$29.70M | −1,484.9% | −$0.37 | −$28.49M |
| FY2018ended Dec 31, 2018 | $17.80M | +2,400.0% | −$22.60M | −127.0% | −$0.41 | −$13.45M |
| FY2016ended Dec 31, 2016 | $712.00K | −92.3% | −$31.51M | −4,425.0% | −$0.62 | −$22.42M |
| FY2015ended Dec 31, 2015 | $9.28M | −25.0% | — | — | — | — |
| FY2014ended Dec 31, 2014 | $12.37M | — | — | — | — | — |
Company profile
- Name
- Compugen Ltd.
- Ticker
- CGEN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 26 Harokmim Street, Building D, Holon, L3 5885849
- Incorporated in
- L3
- Fiscal year ends
- December
- SEC CIK
- 0001119774
Frequently asked questions
What is Compugen's stock price?
Compugen (CGEN) closed at $632.50 on Oct 9, 2026, up less than 0.01% from the previous close of $632.48.
What is Compugen's market cap?
Compugen's market cap is $59.80B, based on a share price of $632.50 and 94.6M shares outstanding as of Dec 31, 2025.
How much revenue does Compugen make?
Compugen reported revenue of $72.76M for fiscal 2025, up 161.14% from fiscal 2024.
Sources and methodology
Fundamentals come from Compugen Ltd.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures